Class information for: |
Basic class information |
Class id | #P | Avg. number of references |
Database coverage of references |
---|---|---|---|
26108 | 263 | 46.6 | 85% |
Hierarchy of classes |
The table includes all classes above and classes immediately below the current class. |
Cluster id | Level | Cluster label | #P |
---|---|---|---|
0 | 4 | BIOCHEMISTRY & MOLECULAR BIOLOGY//CELL BIOLOGY//ONCOLOGY | 4064930 |
405 | 3 | BACTERIORHODOPSIN//G PROTEIN COUPLED RECEPTOR//G PROTEIN | 29641 |
705 | 2 | G PROTEIN COUPLED RECEPTOR//GPCR//RHODOPSIN | 12950 |
26108 | 1 | BIOCHEM TECHNOL SCI TECHNOL//GPR35//RESONANT WAVEGUIDE GRATING BIOSENSOR | 263 |
Terms with highest relevance score |
rank | Term | termType | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|---|
1 | BIOCHEM TECHNOL SCI TECHNOL | address | 2730305 | 10% | 87% | 27 |
2 | GPR35 | authKW | 1458861 | 6% | 74% | 17 |
3 | RESONANT WAVEGUIDE GRATING BIOSENSOR | authKW | 1044934 | 3% | 100% | 9 |
4 | REBINDING | authKW | 784849 | 5% | 52% | 13 |
5 | LIGAND DIRECTED FUNCTIONAL SELECTIVITY | authKW | 580519 | 2% | 100% | 5 |
6 | DYNAMIC MASS REDISTRIBUTION | authKW | 522458 | 3% | 50% | 9 |
7 | MOL BIOCHEM PHARMACOL | address | 386586 | 10% | 13% | 26 |
8 | DRUG TARGET RESIDENCE TIME | authKW | 348311 | 1% | 100% | 3 |
9 | CROMOLYN DISODIUM | authKW | 232208 | 1% | 100% | 2 |
10 | ELECTRIC BIOSENSOR | authKW | 232208 | 1% | 100% | 2 |
Web of Science journal categories |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|
1 | Pharmacology & Pharmacy | 1619 | 46% | 0% | 121 |
2 | Chemistry, Medicinal | 518 | 14% | 0% | 36 |
3 | Biochemical Research Methods | 268 | 11% | 0% | 30 |
4 | Biochemistry & Molecular Biology | 130 | 22% | 0% | 58 |
5 | Biophysics | 121 | 9% | 0% | 23 |
6 | Chemistry, Analytical | 86 | 9% | 0% | 24 |
7 | Biotechnology & Applied Microbiology | 63 | 8% | 0% | 21 |
8 | Cell Biology | 23 | 7% | 0% | 18 |
9 | Electrochemistry | 6 | 2% | 0% | 5 |
10 | Toxicology | 3 | 2% | 0% | 5 |
Address terms |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|
1 | BIOCHEM TECHNOL SCI TECHNOL | 2730305 | 10% | 87% | 27 |
2 | MOL BIOCHEM PHARMACOL | 386586 | 10% | 13% | 26 |
3 | MED COUNCIL TECHNOL | 232208 | 1% | 100% | 2 |
4 | BIOCHEM TECHNOL | 184349 | 10% | 6% | 27 |
5 | BIOL CAXIAS DO SUL | 116104 | 0% | 100% | 1 |
6 | CERTARA QUANTITAT SYST PHARMACOL | 116104 | 0% | 100% | 1 |
7 | CHEST DISCOVERY | 116104 | 0% | 100% | 1 |
8 | COMPUTAT SCI CRYSTALLOG GRP | 116104 | 0% | 100% | 1 |
9 | EFAR | 116104 | 0% | 100% | 1 |
10 | ELTE IMMUNOL GRP | 116104 | 0% | 100% | 1 |
Journals |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|
1 | EXPERT OPINION ON DRUG DISCOVERY | 16779 | 5% | 1% | 12 |
2 | JOURNAL OF BIOMOLECULAR SCREENING | 6762 | 4% | 1% | 10 |
3 | JOURNAL OF RECEPTORS AND SIGNAL TRANSDUCTION | 4702 | 2% | 1% | 5 |
4 | ASSAY AND DRUG DEVELOPMENT TECHNOLOGIES | 4240 | 2% | 1% | 5 |
5 | DRUG DISCOVERY TODAY | 2308 | 3% | 0% | 7 |
6 | MEDCHEMCOMM | 2143 | 2% | 0% | 5 |
7 | NATURE REVIEWS DRUG DISCOVERY | 1977 | 2% | 0% | 4 |
8 | FUNDAMENTAL & CLINICAL PHARMACOLOGY | 1421 | 2% | 0% | 5 |
9 | BRITISH JOURNAL OF PHARMACOLOGY | 1268 | 5% | 0% | 14 |
10 | CURRENT OPINION IN PHARMACOLOGY | 1230 | 2% | 0% | 4 |
Author Key Words |
Core articles |
The table includes core articles in the class. The following variables is taken into account for the relevance score of an article in a cluster c: (1) Number of references referring to publications in the class. (2) Share of total number of active references referring to publications in the class. (3) Age of the article. New articles get higher score than old articles. (4) Citation rate, normalized to year. |
Rank | Reference | # ref. in cl. |
Shr. of ref. in cl. |
Citations |
---|---|---|---|---|
1 | DENG, HY , FANG, Y , (2012) DISCOVERY OF NITROPHENOLS AS GPR35 AGONISTS.MEDCHEMCOMM. VOL. 3. ISSUE 10. P. 1270 -1274 | 22 | 81% | 0 |
2 | VAUQUELIN, G , (2016) EFFECTS OF TARGET BINDING KINETICS ON IN VIVO DRUG EFFICACY: K(OFF), K(ON) AND REBINDING.BRITISH JOURNAL OF PHARMACOLOGY. VOL. 173. ISSUE 15. P. 2319 -2334 | 24 | 48% | 4 |
3 | VAUQUELIN, G , (2015) ON THE 'MICRO'-PHARMACODYNAMIC AND PHARMACOKINETIC MECHANISMS THAT CONTRIBUTE TO LONG-LASTING DRUG ACTION.EXPERT OPINION ON DRUG DISCOVERY. VOL. 10. ISSUE 10. P. 1085 -1098 | 35 | 39% | 4 |
4 | WANG, JX , ZHANG, XL , FANG, Y , LIANG, XM , (2016) LABEL-FREE CELL PHENOTYPIC ASSAYS FOR ASSESSING DRUG POLYPHARMACOLOGY.CURRENT PHARMACEUTICAL DESIGN. VOL. 22. ISSUE 21. P. 3190 -3200 | 36 | 36% | 1 |
5 | MACKENZIE, AE , MILLIGAN, G , (2017) THE EMERGING PHARMACOLOGY AND FUNCTION OF GPR35 IN THE NERVOUS SYSTEM.NEUROPHARMACOLOGY. VOL. 113. ISSUE . P. 661 -671 | 30 | 28% | 1 |
6 | DENG, HY , HU, HB , HE, MQ , HU, JY , NIU, WJ , FERRIE, AM , FANG, Y , (2011) DISCOVERY OF 2-(4-METHYLFURAN-2(5H)-YLIDENE)MALONONITRILE AND THIENO[3,2-B]THIOPHENE-2-CARBOXYLIC ACID DERIVATIVES AS G PROTEIN-COUPLED RECEPTOR 35 (GPR35) AGONISTS.JOURNAL OF MEDICINAL CHEMISTRY. VOL. 54. ISSUE 20. P. 7385 -7396 | 18 | 82% | 12 |
7 | DENG, HY , WANG, CM , SU, M , FANG, Y , (2012) PROBING BIOCHEMICAL MECHANISMS OF ACTION OF MUSCARINIC M3 RECEPTOR ANTAGONISTS WITH LABEL-FREE WHOLE CELL ASSAYS.ANALYTICAL CHEMISTRY. VOL. 84. ISSUE 19. P. 8232-8239 | 22 | 67% | 5 |
8 | COPELAND, RA , (2016) THE DRUG-TARGET RESIDENCE TIME MODEL: A 10-YEAR RETROSPECTIVE.NATURE REVIEWS DRUG DISCOVERY. VOL. 15. ISSUE 2. P. 87 -95 | 16 | 34% | 23 |
9 | VAUQUELIN, G , (2012) DETERMINATION OF DRUG-RECEPTOR RESIDENCE TIMES BY RADIOLIGAND BINDING AND FUNCTIONAL ASSAYS: EXPERIMENTAL STRATEGIES AND PHYSIOLOGICAL RELEVANCE.MEDCHEMCOMM. VOL. 3. ISSUE 6. P. 645-651 | 26 | 47% | 8 |
10 | FANG, Y , (2014) LABEL-FREE DRUG DISCOVERY.FRONTIERS IN PHARMACOLOGY. VOL. 5. ISSUE . P. - | 30 | 38% | 5 |
Classes with closest relation at Level 1 |